Drug Trial Radar · NCT07107256
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
246
Actual
Start
Sep 25, 2025
Primary completion
Mar 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Aug 6, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
TQC2731 injection is a humanized monoclonal antibody that targets Thymic Stromal Lymphopoietin (TSLP), blocks the TSLP pathway, and inhibits the production of downstream cytokines, thereby exerting anti-inflammatory effects. The purpose of this study is to evaluate the efficacy and safety of TQC2731 injection in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Conditions
- Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Interventions
TQC2731 injectionDrug
TQC2731 injection is a humanized monoclonal antibody that targets TSLP, blocks the TSLP signaling pathway, inhibits the production of downstream cytokines, and exerts anti-inflammatory effects.
Placebo of TQC2731Drug
TQC2731 injection is a humanized monoclonal antibody that targets TSLP, blocks the TSLP signaling pathway, inhibits the production of downstream cytokines, and exerts anti-inflammatory effects.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Nasal Polyp Score (NPS)Time frame: From baseline to Week 24
- Nasal Congestion Score (NCS)Time frame: From baseline to Week 24
- Change in nasal polyp score (NPS) from baselineTime frame: From baseline to Week 24
- Change from baseline in Nasal Congestion Score (NCS)Time frame: From baseline to Week 24
Locations
60 sites in 1 country. Site status is shown where the registry gives one.
Zhongda Hosiptal Southeast University
Fuyang, Anhui, China
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Peking University People'S Hospital
Beijing, Beijing Municipality, China
Beijing youan hospital,capital medical university
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China
The 940th Hospital of Joint Logistics Support force of Chinese People 's Liberation Army
Lanzhou, Gansu, China
The Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Shenzhen Second People'S Hospital
Shenzhen, Guangdong, China
Liuzhou People's Hospital
Liuzhou, Guangxi, China
Cangzhou Central Hospital
Cangzhou, Hebei, China
Hebei Petro China Central Hospital
Langfang, Hebei, China
Hebei Medical University Third Hospital
Shijiazhuang, Hebei, China
The First Affiliated Hospital of Hebei North University
Zhangjiakou, Hebei, China
Daqing People's Hospital
Daqing, Heilongjiang, China
Henan Provincial People'S Hospital
Zhengzhou, Henan, China
Jingzhou Central Hospital
Jingzhou, Hubei, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
The First People's Hospital of Changde City
Changde, Hunan, China
People's Hospital of Hunan Province
Changsha, Hunan, China
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
Chifeng Municipal Hospital
Chifeng, Inner Mongolia, China
Affiliated Hospital of Inner Mongolia Medical University
Hohhot, Inner Mongolia, China
The First People'S Hospital of Lianyungang
Lianyungang, Jiangsu, China
Zhongda Hospital affiliated to Southeast University
Nanjing, Jiangsu, China
Jiangnan University Medical Center
Wuxi, Jiangsu, China
Xuzhou Medical University Affiliated Hospital
Xuzhou, Jiangsu, China
Affiliated Hospital of Yangzhou Univrtsity
Yangzhou, Jiangsu, China
Fengcheng People's Hospital
Fengcheng, Jiangxi, China
Ganzhou People's Hospital
Ganzhou, Jiangxi, China
The First Affiliated Hospital of NanChang University
Nanchang, Jiangxi, China
ShangRao People's Hospital
Shangrao, Jiangxi, China
China-Japan Union Hospital of Jilin University
Changchun, Jilin, China
The first hospital of Jilin University
Changchun, Jilin, China
Affiliated Zhongshan Hospital Of Dalian University
Dalian, Jilin, China
China Medical University Affiliated Shengjing Hospital
Shenyang, Liaoning, China
The Second Affiliated Hospital Of Xi'an Jiaotong University
Xi'an, Shaanxi, China
The First Affiliated Hospital of Xi'an Jiao Tong University
Xi'an, Shaanxi, China
Yan'an University Xianyang Hospital
Xianyang, Shaanxi, China
Shandong Second Province General Hospital
Jinan, Shandong, China
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.